Back to Search
WILLIAM CANCE, MD
MD
Surgical Oncology Physician
NPI: 1093721730Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Neurofibromin physically interacts with the N-terminal domain of focal adhesion kinase.
PMID 19479903·Mol Carcinog·2009
7-preclinical
FAK overexpression and p53 mutations are highly correlated in human breast cancer.
PMID 19521985·Int J Cancer·2009
8-other
Small molecule chloropyramine hydrochloride (C4) targets the binding site of focal adhesion kinase and vascular endothelial growth factor receptor 3 and suppresses breast cancer growth in vivo.
PMID 19610651·J Med Chem·2009
7-preclinical
Targeting of the protein interaction site between FAK and IGF-1R.
PMID 19664602·Biochem Biophys Res Commun·2009
8-other
A pilot prospective randomized trial of postoperative epoetin alfa in patients undergoing major operation for upper gastrointestinal malignancy.
PMID 19675446·Am J Clin Oncol·2009
2-rct
The direct effect of focal adhesion kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis.
PMID 19671193·BMC Cancer·2009
7-preclinical
Specific tyrosine phosphorylation of focal adhesion kinase mediated by Fer tyrosine kinase in suspended hepatocytes.
PMID 19339212·Biochim Biophys Acta·2009
7-preclinical
A novel small molecule inhibitor of FAK decreases growth of human pancreatic cancer.
PMID 19571674·Cell Cycle·2009
7-preclinical
Is there an indication for initial conservative management of pancreatic cystic lesions?
PMID 19267387·J Surg Oncol·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 625 N 6TH ST
PHOENIX, AZ 85004 - Phone
- (602) 406-8222
Quick Facts
- NPI
- 1093721730
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile